scispace - formally typeset
G

Guideng Li

Researcher at Peking Union Medical College

Publications -  45
Citations -  2016

Guideng Li is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & T cell. The author has an hindex of 21, co-authored 38 publications receiving 1468 citations. Previous affiliations of Guideng Li include University of California, Irvine & University of California.

Papers
More filters
Journal ArticleDOI

Cytosporone B is an agonist for nuclear orphan receptor Nur77

TL;DR: The octaketide cytosporone B (Csn-B) is a naturally occurring agonist for Nur77 that induced apoptosis and retarded xenograft tumor growth by inducing Nur77 expression, translocating Nur77 to mitochondria to cause cytochrome c release and may be useful as a reagent to increase understanding of Nur77 biological function.
Journal ArticleDOI

BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway

TL;DR: It is shown that BCR-signalling synergizes with Toll-like receptor (TLR) signalling to induce class switch DNA recombination, and by integrating signals of the non-canonical and canonical NF-κB pathways, BCR and TLRs synergize to induce AID and T-cell-independent class switchDNA recombination.
Journal ArticleDOI

Alternative mRNA splicing in cancer immunotherapy

TL;DR: The promise of analysing mRNA processing events in cancer cells, with an emphasis on mRNA splicing, for the identification of potential new targets for cancer immunotherapy is discussed.
Journal ArticleDOI

Functional TCR T cell screening using single-cell droplet microfluidics

TL;DR: The TCR screening prototype will facilitate immunotherapeutic screening and development of T cell therapies and use droplet microfluidics for functional screening and real-time monitoring of single TCR T cell activation upon recognition of target tumor cells.
Journal ArticleDOI

T cell antigen discovery via trogocytosis.

TL;DR: A cell-based selection platform for TCR ligand discovery that exploits a membrane transfer phenomenon called trogocytosis and allows the identification of neoepitopes targeted by T cell receptors with high sensitivity is developed.